Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063489 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability
A Phase 1 study of Eye Pain, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 6
- Study locations
NCT03063489: Completed Phase 1 study of Eye Pain, sponsored by Bausch Health Americas.
NCT03063489 is a Phase 1 study of Eye Pain that has completed, run by Bausch Health Americas. The registered enrollment target is 15 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03063489, a Phase 1 study of Eye Pain, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 6
- Study locations
Study Summary
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers
Conditions Studied
Interventions
- DRUG Loteprednol Etabonate Ophthalmic Gel
Study Locations (6)
Missouri
- Valeant Site 06 - Kansas City
- Valeant Site 02 - St Louis
Arizona
- Valeant Site 01 - Phoenix
California
- Valeant Site 03 - Oceanside
Florida
- Valeant Site 05 - Miami
Massachusetts
- Valeant Site 04 - Quincy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-07 |
| Phase | Phase 1 |
What the finished NCT03063489 record still lists
NCT03063489 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Eye Pain appearing as the primary indexed condition, and to 1 intervention - of which Loteprednol Etabonate Ophthalmic Gel is the first listed.
NCT03063489 lists 6 locations in 5 states (Missouri, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT03063489 about?
NCT03063489 is a clinical study titled "Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability". Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers
What is the current status of trial NCT03063489?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2015-02. Estimated completion is 2015-07.
What conditions does trial NCT03063489 study?
This clinical trial studies the following conditions: Eye Pain.
What interventions are being tested in trial NCT03063489?
The interventions under investigation include: Loteprednol Etabonate Ophthalmic Gel (DRUG).
Who is sponsoring clinical trial NCT03063489?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03063489 being conducted?
This trial has 6 study locations across Arizona, California, Florida, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03063489's enrollment target sits among peer trials
15 1798th of 2000 higher than 157 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia